Generic Giant: Dr. Reddy’s Acquires Betapharm Group
This article was originally published in The Pink Sheet Daily
Executive Summary
With the $576 mil. acquisition of Betapharm, Dr. Reddy’s will expand its presence in Europe.
You may also be interested in...
Dr. Reddy’s Laboratories Buys U.K. Dow Chemical Drug Units
Move bolsters India firm’s contract research capabilities.
Dr. Reddy’s Laboratories Buys U.K. Dow Chemical Drug Units
Move bolsters India firm’s contract research capabilities.
Indian Drug Companies Increasingly Active In Global M&A
Indian drug companies are actively making acquisitions and partnering deals in Europe and the U.S. in order to expand their geographic reach